These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20584285)

  • 1. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.
    De Chiara L; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Cordero OJ; Martínez-Ares D; Páez de la Cadena M
    BMC Cancer; 2010 Jun; 10():333. PubMed ID: 20584285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.
    Otero-Estévez O; De Chiara L; Rodríguez-Berrocal FJ; Páez de la Cadena M; Cubiella J; Castro I; Gonzalez-Mao C; Hernandez V; Martínez-Zorzano VS
    Br J Cancer; 2015 Jan; 112(2):375-81. PubMed ID: 25461801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of serum dipeptidyl peptidase (DPP- IV) /CD26 as a serum marker in Egyptian patients with colorectal cancer.
    Elzefzafy WM; Abd Elrahman S; Mohmmed ZA; Atef N
    J Immunoassay Immunochem; 2020 Jul; 41(4):729-744. PubMed ID: 32223519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.
    Tao S; Haug U; Kuhn K; Brenner H
    Br J Cancer; 2012 Apr; 106(8):1424-30. PubMed ID: 22454079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD26 levels and its association to epidemiologic parameters in a sample population.
    De Chiara L; Rodríguez-Piñeiro AM; Cordero OJ; Rodríguez-Berrocal FJ; Ayude D; Rivas-Hervada And FJ; de la Cadena MP
    Dis Markers; 2009; 27(6):311-6. PubMed ID: 20075514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
    De Chiara L; Páez de la Cadena M; Rodríguez-Berrocal J; Alvarez-Pardiñas MC; Pardiñas-Añón MC; Varela-Calviño R; Cordero OJ
    Dis Markers; 2020; 2020():4347936. PubMed ID: 32051696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.
    De Chiara L; Rodríguez-Piñeiro AM; Cordero OJ; Vázquez-Tuñas L; Ayude D; Rodríguez-Berrocal FJ; de la Cadena MP
    PLoS One; 2014; 9(9):e107470. PubMed ID: 25210927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
    Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
    Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of colorectal cancer in individuals with serrated polyps.
    Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
    Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps.
    Fliss-Isakov N; Zelber-Sagi S; Webb M; Halpern Z; Shibolet O; Kariv R
    Obesity (Silver Spring); 2017 Nov; 25 Suppl 2():S72-S80. PubMed ID: 29086511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of soluble CD26 as a serum marker for colorectal cancer detection.
    Cordero OJ; Imbernon M; Chiara LD; Martinez-Zorzano VS; Ayude D; de la Cadena MP; Rodriguez-Berrocal FJ
    World J Clin Oncol; 2011 Jun; 2(6):245-61. PubMed ID: 21773075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.
    Crockett SD; Mott LA; Barry EL; Figueiredo JC; Burke CA; Baxter GJ; Sandler RS; Baron JA
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1122-7. PubMed ID: 25145487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
    Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
    Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
    Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
    Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.
    Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ
    J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution characteristics and risk factors of colorectal adenomas].
    Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between proximal and distal colonic adenomas: is screening sigmoidoscopy enough in the presence of a changing epidemiology?
    Lucendo AJ; Guagnozzi D; Angueira T; González-Castillo S; Fernández-Fuente M; Friginal-Ruiz AB; Tenias JM
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):973-80. PubMed ID: 23571611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.